1. Home
  2. Knowledge
  3. Courses
  4. GLP-1 basics course
  5. Lesson 2: The medications
Course

Lesson 2: The medications at a glance

Brand names like Ozempic, Mounjaro or Saxenda come down to four active substances. This lesson sorts them by mechanism, form and approval.

Updated Nov 21, 20264 min readBeBetr editorial teamCreated with AI assistance

In short

  • Semaglutide, liraglutide and dulaglutide act on the GLP-1 receptor; tirzepatide also acts on the GIP receptor.
  • Liraglutide is injected daily; semaglutide, dulaglutide and tirzepatide weekly. Semaglutide also comes as a tablet.
  • In the EU, products with semaglutide, tirzepatide and liraglutide are approved for weight management; dulaglutide only for type 2 diabetes.

One principle, different molecules

Lesson 1 showed that the body's own GLP-1 is gone within minutes. Every medication in this lesson gets around that, each in its own way: they are chemically modified to stay in the blood for hours or days. That is what decides whether a product is used daily or once a week.

Three of the four are GLP-1 receptor agonists: they bind where the natural hormone binds. Tirzepatide is a dual agonist that also switches on the receptor for a second gut hormone, GIP. Both hormones are incretins.

The four medications side by side

SubstanceMechanismProducts (EU)FormApproved for (EU)
SemaglutideGLP-1Ozempic, Wegovy, Rybelsusweekly pen (Ozempic, Wegovy), daily tablet (Rybelsus)type 2 diabetes (Ozempic, Rybelsus), weight management (Wegovy)
TirzepatideGIP and GLP-1Mounjaroweekly pentype 2 diabetes and weight management
LiraglutideGLP-1Victoza, Saxendadaily pentype 2 diabetes (Victoza), weight management (Saxenda)
DulaglutideGLP-1Trulicityweekly pentype 2 diabetes

The exact indications – for example the BMI threshold for weight management or the minimum age – are set out in each product's information and are updated over time.

Why daily or weekly?

It comes down to the half-life: how long it takes for half of the substance to be cleared. According to the product information it is about 13 hours for liraglutide, around 5 days for dulaglutide and tirzepatide, and about a week for semaglutide. Oral semaglutide (Rybelsus) is a special case: to be absorbed in the stomach it has to be taken following set rules around food and drink, which are explained in the package leaflet.

What they all share

  • Prescription only: every product is available only on prescription from a pharmacy.
  • A gradual start: the dose is not given in full straight away but raised in steps by the doctor – this is called titration. The right dose is decided by your doctor.
  • Similar side effects: according to the product information the most common are gastrointestinal – nausea, diarrhoea, vomiting and constipation.

How semaglutide and tirzepatide compared head to head in trials is covered in semaglutide vs tirzepatide. There is also a full profile of semaglutide.

What this means for you

Which medication is suitable depends on diagnosis, other conditions, tolerability and reimbursement – that is a medical decision. What matters for you is knowing your own routine: daily or weekly, pen or tablet. In the BeBetr app you can log your medication, each dose taken and any side effects, and show the history at your next appointment. Lesson 3 covers the first weeks after starting.

Important: GLP-1 substances are also sold online as “research peptides” or without a prescription. Such products are untested and may be wrongly dosed or contaminated. Genuine products are available only on prescription from a pharmacy.
Protocol in the app

Doses, injection sites and supply at a glance

Document your prescribed therapy: reminders, injection-site rotation, vials and history – privately synced.

Quick quiz

Which medication activates the GIP receptor as well as the GLP-1 receptor?

Tirzepatide is a dual GIP and GLP-1 receptor agonist. The other three act only on the GLP-1 receptor.

Which medication is injected daily?

Liraglutide has a half-life of about 13 hours, so it is used once a day.

What is dulaglutide (Trulicity) approved for in the EU?

In the EU, Trulicity is approved for type 2 diabetes, not for weight management.

Sources

  1. EMA: Ozempic (semaglutide) – product information
  2. EMA: Wegovy (semaglutide) – product information
  3. EMA: Rybelsus (semaglutide) – product information
  4. EMA: Mounjaro (tirzepatide) – product information
  5. EMA: Victoza (liraglutide) – product information
  6. EMA: Saxenda (liraglutide) – product information
  7. EMA: Trulicity (dulaglutide) – product information

Written by the BeBetr editorial team with AI assistance; facts checked against the sources listed (as of Nov 21, 2026). This content is for information only and does not replace medical advice, diagnosis or treatment.

Keep reading